Compound
Active substance:
mebhydroline napadisylate 100 mg;

Indications
Hay fever (hay fever), allergic conjunctivitis, urticaria, drug rash, skin reaction after an insect bite, allergic dermatoses accompanied by itchy skin.
Use during pregnancy and breastfeeding
It is not recommended to take during pregnancy and lactation.

Contraindications
Hypersensitivity to the components of the drug, prostatic hyperplasia, angle-closure glaucoma, peptic ulcer of the stomach and duodenum, inflammatory diseases of the gastrointestinal tract, pyloric stenosis, epilepsy, heart rhythm disturbances, pregnancy, lactation, children under 3 years of age.

Carefully
Hepatic and/or renal failure (dose adjustment and intervals between doses may be required.

Side effects
From the digestive system: dyspepsia caused by the irritating effect of the drug on the mucous membrane of the gastrointestinal tract (heartburn, nausea, pain in the epigastric region).
Other: dry mouth, urinary retention, allergic reactions, extremely rarely - granulocytopenia and agranulocytosis.
From the nervous system: dizziness, paresthesia, tremor, increased fatigue, drowsiness, anxiety (at night), slowdown in the speed of psychomotor reactions.
Paradoxical reactions are possible in children: increased excitability, irritability, tremors, sleep disturbances.

Storage conditions
In a dry place, protected from light, at a temperature below 25 °C

Best before date
3 years 6 months. Do not use after the expiration date stated on the packaging.